182 related articles for article (PubMed ID: 9841888)
41. Apoptotic responsiveness of PC-3 prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand: evidence for differential effects of Bcl-xL and Bcl-2 down-regulation.
Sonnemann J; Gekeler V; Sagrauske A; Müller C; Hofmann HP; Beck JF
Int J Oncol; 2004 Oct; 25(4):1171-81. PubMed ID: 15375570
[TBL] [Abstract][Full Text] [Related]
42. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP.
Mühlethaler-Mottet A; Bourloud KB; Auderset K; Joseph JM; Gross N
Oncogene; 2004 Jul; 23(32):5415-25. PubMed ID: 15094781
[TBL] [Abstract][Full Text] [Related]
43. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
Mori M; Uchida M; Watanabe T; Kirito K; Hatake K; Ozawa K; Komatsu N
J Cell Physiol; 2003 May; 195(2):290-7. PubMed ID: 12652655
[TBL] [Abstract][Full Text] [Related]
44. Bcl-xL inhibits different apoptotic pathways in rat PC12 cells.
Lindenboim L; Haviv R; Stein R
Neurosci Lett; 1998 Aug; 253(1):37-40. PubMed ID: 9754799
[TBL] [Abstract][Full Text] [Related]
45. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation.
Hu Y; Benedict MA; Wu D; Inohara N; Núñez G
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4386-91. PubMed ID: 9539746
[TBL] [Abstract][Full Text] [Related]
46. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis.
Chu F; Borthakur A; Sun X; Barkinge J; Gudi R; Hawkins S; Prasad KV
Apoptosis; 2004 Jan; 9(1):83-95. PubMed ID: 14739602
[TBL] [Abstract][Full Text] [Related]
47. Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis.
Tepper AD; de Vries E; van Blitterswijk WJ; Borst J
J Clin Invest; 1999 Apr; 103(7):971-8. PubMed ID: 10194469
[TBL] [Abstract][Full Text] [Related]
48. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes.
Rohrbach S; Muller-Werdan U; Werdan K; Koch S; Gellerich NF; Holtz J
J Mol Cell Cardiol; 2005 Mar; 38(3):485-93. PubMed ID: 15733908
[TBL] [Abstract][Full Text] [Related]
49. BP1 transcriptionally activates bcl-2 and inhibits TNFalpha-induced cell death in MCF7 breast cancer cells.
Stevenson HS; Fu SW; Pinzone JJ; Rheey J; Simmens SJ; Berg PE
Breast Cancer Res; 2007; 9(5):R60. PubMed ID: 17854498
[TBL] [Abstract][Full Text] [Related]
50. Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway.
Dbaibo GS; Perry DK; Gamard CJ; Platt R; Poirier GG; Obeid LM; Hannun YA
J Exp Med; 1997 Feb; 185(3):481-90. PubMed ID: 9053448
[TBL] [Abstract][Full Text] [Related]
51. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
52. Two CD95 (APO-1/Fas) signaling pathways.
Scaffidi C; Fulda S; Srinivasan A; Friesen C; Li F; Tomaselli KJ; Debatin KM; Krammer PH; Peter ME
EMBO J; 1998 Mar; 17(6):1675-87. PubMed ID: 9501089
[TBL] [Abstract][Full Text] [Related]
53. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
54. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice.
de la Coste A; Fabre M; McDonell N; Porteu A; Gilgenkrantz H; Perret C; Kahn A; Mignon A
Am J Physiol; 1999 Sep; 277(3):G702-8. PubMed ID: 10484397
[TBL] [Abstract][Full Text] [Related]
55. Early activation of the mitochondrial apoptotic pathway in Vesicular Stomatitis virus-infected cells.
Gadaleta P; Perfetti X; Mersich S; Coulombié F
Virus Res; 2005 Apr; 109(1):65-9. PubMed ID: 15826914
[TBL] [Abstract][Full Text] [Related]
56. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
57. Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways.
Tsujimoto Y; Shimizu S; Eguchi Y; Kamiike W; Matsuda H
Leukemia; 1997 Apr; 11 Suppl 3():380-2. PubMed ID: 9209397
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
Fontana JA; Sun RJ; Rishi AK; Dawson MI; Ordónez JV; Zhang Y; Tschang SH; Bhalla K; Han Z; Wyche J; Poirer G; Sheikh MS; Shroot B; Reichert U
Oncol Res; 1998; 10(6):313-24. PubMed ID: 9848102
[TBL] [Abstract][Full Text] [Related]
59. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
60. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents.
Decaudin D; Geley S; Hirsch T; Castedo M; Marchetti P; Macho A; Kofler R; Kroemer G
Cancer Res; 1997 Jan; 57(1):62-7. PubMed ID: 8988042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
